- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00280904
A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus
Study Overview
Detailed Description
Clinical trials show that the majority of infections in shunt systems originate from bacterial contamination introduced at the time of surgery and most appear by 3-4 weeks post-operatively. Protection must persist well beyond the surgical procedure to make certain that all contaminating bacteria are completely eradicated.
Depending upon the institution, shunt infection rates have been known to be as little as 1% to as much as 25%. However, two prospective trials that have been published from large databases, with a consistent definition of infection, have indicated an overall infection rate of approximately 10%
This prospective non-randomized, open-label Registry is designed to investigate and identify short-term shunt/catheter-related infection rates in ventriculoperitoneal shunt systems using various catheters during hospital standard of care treatment of Subjects with hydrocephalus. Prospective Subjects will include those receiving shunts for the first time (de novo) and those with previously implanted shunts for whom catheter or total system replacements are required.
This Registry will enroll 450 implanted Subjects of any age who meet all the inclusion criteria and none of the exclusion criteria and who provide signed Informed Consent to participate in this clinical Registry
Subjects will be followed for up to 90 days.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3V4
- British Columbia Children's Hospital
-
-
-
-
-
Beijing, China
- Prince of Wales Hospital
-
Shanghai, China, 200040
- Ua Shan Hospital
-
-
-
-
-
Hong Kong, Hong Kong
- Queen Mary Hospital
-
-
-
-
-
New Delhi, India, 110029
- All India Insitute of Medical Sciences
-
-
-
-
-
Singapore, Singapore, 308433
- National Neuroscience Institute
-
-
-
-
Illinois
-
Chicago, Illinois, United States, 60614
- Children's Memorial Hospital
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Penn State Milton S. Hershey Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The Subject requires a surgical procedure to implant (de novo) a ventriculoperitoneal shunt or to replace an already implanted shunt catheter for the treatment of hydrocephalus.
- The Subject (family member/legal representative) has completed the Informed Consent process prior to enrollment into this Registry.
- The Subject (family member/legal representative) is willing to comply with the Registry protocol timelines & requirements.
Exclusion Criteria:
- The Subject's planned shunt has distal drainage to the heart.
- The Subject has an active infection of the indwelling shunt system, cerebrospinal fluid or abdominal cavity.
- The Subject has ventriculitis, peritonitis or meningitis.
- The Subject has sepsis.
- The Subject has a history of poor wound healing.
- The Subject has symptoms pertaining to: a skin infection at or near the site of any incisions; an ear infection on either side; a respiratory tract infection; or a urinary tract infection that, in the Investigator's opinion is clinically significant and might compromise the outcome of this Registry.
- The Subject has had any form of bowel surgery 30 days prior to device implant or anticipates bowel surgery within 90 days following device implant
- The Subject has loculation(s) within the ventricular system.
- The Subject is otherwise determined by the Investigator to be medically unsuitable for participation in this Registry.
- The Subject is currently enrolled in another drug or device trial or has been previously entered in this trial.
- The Subject exhibits other difficulties, which would preclude follow-up for 90 days.
- The Subject is a prisoner.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Subjects With Shunt Infections
Time Frame: Implantation to Explant
|
Number of shunt infections occurring in subjects implanted with antibiotic impregnated catheters and standard catheters.
|
Implantation to Explant
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Non-infectious Antibiotic Impregnated (AI) and Standard Catheter Subjects With Shunt Failures
Time Frame: April 2008
|
April 2008
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Paul Steinbok, MBBS, FRCSC, University of British Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRI-IN04-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydrocephalus
-
University of Kansas Medical CenterNot yet recruitingLow Pressure Hydrocephalus
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Military University Hospital, PragueRecruitingNormal Pressure HydrocephalusCzechia
-
University Hospital, ToulouseCompleted
-
Rabin Medical CenterUnknown
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
Clinical Trials on Shunt catheter
-
University Hospital Inselspital, BerneCompletedKeyhole Surgery for the Positioning of the Distal Catheter in Ventricular Peritoneal Shunt PlacementRandomized Controlled Trial | Ventricular Peritoneal Shunt | Shunt Complications | Shunt FailureSwitzerland
-
Pleural Dynamics, Inc.Not yet recruitingPleural Effusion
-
Johns Hopkins UniversityTerminated
-
Kasr El Aini HospitalCompleted
-
Duke UniversityPediatric Hydrocephalus Foundation; Children's Miracle Network HospitalsCompletedCommunicating HydrocephalusUnited States
-
NXT BiomedicalNot yet recruiting
-
Linkoeping UniversityRecruitingLeukoencephalopathies | Fecal Incontinence With Fecal Urgency | Diffusion Tensor Imaging | Urine IncontinenceSweden
-
Edwards LifesciencesRecruitingHeart FailureCanada
-
Sun Yat-sen UniversityUnknownHypertension, Portal | Portal Vein, Cavernous Transformation OfChina
-
NXT BiomedicalEnrolling by invitation